| Ytd | -21.72% | |
| 1y | -27.19% |
| Open | 278.02 | Prev Close | 280.13 | Low | 274.38 | High | 279.15 | Mkt Cap | 105.53B |
| Vol | 4.78M | Avg Vol | 2.67M | EPS | 9.66 | P/E | 28.48 | Forward P/E | 16.43 |
| Beta | 0.77 | Short Ratio | 3.27 | Inst. Own | 82.86% | Dividend | 3.52 | Div Yield | 1.26 |
| Ex Div Date | 09-30 | Earning | 10-29 | 50-d Avg | 320.40 | 200-d Avg | 334.39 | 1yr Est | 374.88 |
SYK News
Boston, Massachusetts--(Newsfile Corp. - September 18, 2026) - Block & Leviton is investigating Stry
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price
SYK expands its Foot & Ankle portfolio with Prophecy for Incompass and smartHEX, linking planning, i
SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- On September 8, 2026, investors in Stryker Corpora
Investors looking for stocks in the Medical - Products sector might want to consider either GE Healt
New additions advance surgical planning, implant flexibility and connected care across Stryker's Foo
Stryker's share price has declined significantly in recent months on the back of operational issues,
Citigroup analyst Joanne Wuensch maintains Stryker (NYSE:SYK) with a Buy and lowers the price tar
Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and lowers the
Crude near $98 pushes the 10-year Treasury yield above 4.8% for the first time since 2023, hammering
Stryker (NYSE: SYK), a global leader in medical technologies, announced today that the first surgica
Stryker Corp. stock (ISIN US8636671013) currently trades without any clearly documented new corporat
Today, Stryker Corp. stock is heading into the open with no clearly stamped recent U.S. closing pric